ACHE and Alzheimer disease: Additionally, whereas evidence from current clinical trials indicates beneficial effects of acetylcholinesterase inhibitors [4] and anticancer drugs in AD patients [166], the future application of genetic approaches such as gene therapy [167], including RNA-based therapy [168] and CRISPR [169] represents a new window for AD treatment.